Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-23
2006-05-23
Desai, Rita (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S016000, C546S019000
Reexamination Certificate
active
07049320
ABSTRACT:
A NK1antagonist having the formula (I),wherein Ar1and Ar2are optionally substituted phenyl or heteroaryl, X1is an ether, thio or imino linkage, R4and R5are not both H or alkyl, and the remaining variables are as defined in the specification, useful for treating a number of disorders, including emesis, depression, anxiety and cough. Pharmaceutical compositions. Methods of treatment and combinations with other agents are also disclosed.
REFERENCES:
patent: 5620989 (1997-04-01), Harrison et al.
patent: 5760018 (1998-06-01), Baker et al.
patent: 6162805 (2000-12-01), Hefti
patent: WO 94/10165 (1994-05-01), None
patent: WO 94/13639 (1994-06-01), None
patent: WO 95/19344 (1995-07-01), None
patent: WO 01/44200 (2001-06-01), None
U.S. Appl. No. 10/292,618, filed Nov. 12, 2002, Reichard et al.
Wu et al,Tetrahedron, 56(2000), 3043-3051.
Rombouts et al,Tetrahedron Letters, 42(2001), 7397-7399.
Rogiers et al,Tetrahedron, 57(2001), 8971-8981.
Kramer et al,Science, 281(1998), 1640-1645.
Gonzales et al,Oncology Special Edition, 5(2002), 53-58.
Cogan et al,Tetrahedron, 55(1999), 8883-8904.
Kubik et al,Tetrahedron Letters, 35(1994), 6635-6638.
O'Donnell et al,Heterocyles, 46(1997), 617-630.
Giard et al,Tetrahedron Letters, 40(1999), 5495-5497.
Harrison et al,Biooganic&Med. Chem. Let., 4, No. 23 (1994), 2733-2734.
Wu et al,Tetrahedron, 56(2000), 6279-6290.
Arredondo Juan D.
Palani Anandan
Paliwal Sunil
Reichard Gregory A.
Shih Neng-Yang
Blinka Thomas A.
Desai Rita
Kalyanaraman Palaiyur S.
Magatti Anita W.
Schering Corporation
LandOfFree
NK 1 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with NK 1 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NK 1 antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3611534